Skip to main content
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2008 Nov;14(11):1762–1765. doi: 10.3201/eid1411.080542

Change in Japanese Encephalitis Virus Distribution,Thailand

Narong Nitatpattana 1,2,3,4, Audrey Dubot-Pérès 1,2,3,4, Meriadeg Ar Gouilh 1,2,3,4, Marc Souris 1,2,3,4, Philippe Barbazan 1,2,3,4, Sutee Yoksan 1,2,3,4, Xavier de Lamballerie 1,2,3,4, Jean-Paul Gonzalez 1,2,3,4,
PMCID: PMC2630747  PMID: 18976565

Abstract

Japanese encephalitis virus (JEV) genotypes in Thailand were studied in pigs and mosquitoes collected near houses of confirmed human JEV cases in 2003–2005. Twelve JEV strains isolated belonged to genotype I, which shows a switch from genotype III incidence that started during the 1980s.

Keywords: Japanese encephalitis virus, genotype, Thailand, dispatch


The origin of Japanese encephalitis virus (JEV) was recognized before 1935, and JEV was isolated in Japan in 1935. The virus has since spread from India to Indonesia and within the past 3 decades has reached previously unaffected parts of Asia and northern Australia (1,2). JEV is one of the most widespread causes of viral encephalitis worldwide; an estimated 3 billion persons are at risk for infection, and 10,000 to 15,000 die annually (3). Although most human infections are asymptomatic (1/1,000), 1/300 infections causes symptomatic infections, and 1/4 patients seeking treatment have symptoms of brain inflammation, which can lead to permanent neurologic sequelae and a 1/4 death rate (4).

JEV is a flavivirus transmitted by Culex mosquitoes to birds and pigs; humans are dead-end incidental hosts. On the basis of nucleotide sequencing of capsid/premembrane protein (C/PrM) and envelope (E) genes, 5 virus genotypes have been identified, including genotypes I to III (GI, GII, GIII). These have been found distributed all over southern Asia; a GIV strain was isolated from eastern Indonesia, and an isolate originating in Malaysia may represent a fifth genotype (5).

Three vaccines, derived from JEV GIII strains, are currently in use. Since the 1960s JEV immunization campaigns have dramatically reduced the effects of the disease in southern and Southeast Asia (6). In Thailand, JEV immunization began as a part of childhood vaccination program in the northern provinces in 1990; this program rapidly expanded to 36 provinces that had reported a persistent incidence of encephalitis (7).

The Study

To study the JEV genotype distribution in Thailand and to eventually detect changes in Japanese encephalitis epidemiologic patterns, we conducted a 3-year survey (2003–2005) of JEV incidence in 7 provinces representative of the 4 regions of Thailand (north, Chiang Mai Province; northeast, Khon Khen Province; central plain, Nakhon Pathom, Ratchaburi, and Samut Songkram Provinces; south, Phuket and Chumphon Provinces). Pig farms and rice fields within a 2-km radius around houses of confirmed human cases of Japanese encephalitis were targeted for sample collection. Ten healthy sentinel piglets (10 weeks of age) were surveyed in each province, and blood samples were collected weekly for 14 weeks. Adult mosquitoes were collected on a monthly basis according to the targeted pig farm and availability of breeding sites for vectors (Table 1; Figure 1) by using both the CDC gravid trap (Model 1712) and the CDC light trap (P. Reiter, Centers for Disease Control and Prevention, Fort Collins, CO, USA).

Table 1. Location of Japanese encephalitis virus study sites, Thailand.

Site no. Province Latitude N Longitude E
1 Phuket 43º36′90′′ 88º67′10′′
2 Chiang Mai 50º10′10′′ 21º15′757′′
3 Ratchaburi 58º41′09′′ 15º19′015′′
4 Nakhon Pathom 59º38′49′′ 15º46′044′′
5 Khon Kaen 18º63′72′′ 18º28′276′′
6 Chumphon 09º58′09′′ 99º02′87′′
7 Samut Songkham 13º26′24′′ 100º00′00′′

Figure 1.

Figure 1

Provinces of Thailand showing study sites in Phuket, Chiang Mai, Ratchaburi, Nakhon Pathom, Khon Kaen, Chumphon, and Samut Songkham.

Fifty microliters each from pig serum specimens and from filtered suspension of crushed mosquitoes were used for virus isolation on C6/36 cells. We tested JEV propagation by immunofluorescent assay. RNA extraction was done from a supernatant of JEV-positive cell culture, after first passage, according to manufacturer’s protocol as well as RNA reverse transcription–PCR (RT-PCR) (GIBCO-BRL, Gaithersburg, MD, USA). RT-PCR was performed on 4 μL of cDNA template by using 2.5 units of AmpliTaq Gold DNA Polymerase (PerkinElmer, Foster City, CA, USA). Overlapping JEV E gene fragments were amplified with 2 sets of primers: Ea forward primer (5′-ATA GTA GCT ATG TGT GCA AAC AAG G 5-3′), Ea reverse primer (5′-GAA TTC RGT YGT GCC YTT CAG AGC-3′); and Eb forward primer (5′-AGC TCA GTR AAG TTR ACA TCA GG-3′), Eb reverse primer (5′-GAA TTC AAT GGC ACA KCC WGT GTC-3′), respectively (8). The 1,216 nucleotides generated partial sequences of the JEV E gene that were compiled by using Sequence-Alignment Editor software version 2.0a11 (A. Rambaut, Department of Zoology, University of Oxford, Oxford, UK); pairwise genetic distances were calculated with MEGA software version 2.0 (9) (Table 2; Figure 2).

Table 2. Strains of Japanese encephalitis virus used for phylogenetic analysis*.

Strain Year Location Source Genotype GenBank accession no.
FU 1995 Australia Human II AF217620
P3 1949 China Mosquito† III AY243844
Beijing-1 1949 China Human brain III L48961
JKT7003 1981 Indonesia Mosquito† IV U70408
JKT5441 1981 Indonesia Mosquito† II U70406
Nakayama 1935 Japan Human brain III AF112297
JaOArS7485 1985 Japan Unavailable III AB028259
JaNAr0102 2002 Japan Pig blood I AY377577
K94P05 1994 Korea Mosquito† I U34929
WTP 1970 Malaysia Mosquito† II U70421
DH20 1985 Nepal Human brain III U03690
PhAn1242 1984 Philippines Pig III U70417
HK8256 1982 Taiwan Mosquito† III U70396
Chiang Mai 1964 Chiang Mai, N Thailand† Human III U70393
P19Br 1982 Chiang Mai, N Thailand Human brain I U70416
KPPO34-35CT 1982 Khon Khen, NE Thailand† Mosquito† III U03693
B1065 1983 South Thailand Pig II U70388
B2239 1984 Chiang Mai, N Thailand Pig blood I U70391
ThCMAr4492 1992 Chiang Mai, N Thailand Mosquito† I D45362
JE_CM_1196 2005 Chiang Mai, N Thailand Pig I DQ238602
JE_KK_80 2004 Khon Khen, NE Thailand Pig I DQ111784
JE_KK_82 2004 Khon Khen, NE Thailand Pig I DQ111785
JE_KK_83 2004 Khon Khen, NE Thailand Pig I DQ111787
JE_KK_87 2004 Khon Khen, NE Thailand Pig I DQ111788
JE_KK_577 2005 Khon Khen, NE Thailand Pig I DQ238601
JE_KK_580 2005 Khon Khen, NE Thailand Pig I DQ238600
JE_KK_1116 2005 Khon Khen, NE Thailand Pig I DQ343290
JE_RT_36 2003 Ratchaburi, Central plain Thailand Mosquito‡ I DQ087975
JE_CP_49 2004 Chumphon, S Thailand Pig I DQ087974
JE_CP_67 2004 Chumphon, S Thailand Pig I DQ087972
JE_PK52 2004 Phuket, S Thailand Mosquito§ I DQ084229
VN118 1979 Vietnam Mosquito† III U70420
02VN22 2002 Vietnam Pig blood I AY376465
Murray Valley E.1-51 1951 Australia Human AF161266

*N, northern; NE, northeastern; S, southern.
†Unidentified species.
‡Culex tritaeniorhynchus.
§Cx. quinquefasciatus.

Figure 2.

Figure 2

Sequence phylogeny based on E (envelope) gene nucleotide sequence of Japanese encephalitis virus isolates from pigs and mosquito hosts in Thailand during 2003–2005, with reference to other Southeast Asian isolates. Phylogenetic analysis was performed by using nucleotide alignments, the Kimura 2-parameter algorithm (for the calculation of pairwise distances), and the neighbor-joining method (for tree reconstruction), as implemented in MEGA software (9). The tree was rooted within the Japanese encephalitis serogoup by using Murray Valley virus (GenBank accession nos. E1–51). The robustness of branching patterns was tested by 1,000 bootstrap pseudoreplications. Each strain is abbreviated, followed by the country of origin (and the region of origin in Thailand, e.g., NE = northeast) and year of isolation. Bootstrap values are indicated above the major branch; 33 taxa comprised the ingroup, and all taxa were rooted with Murray Valley virus. A unique gap was treated as a "fifth base." The character state optimization was chosen as accelerated transformation. Consistence index 0.572; retention index 0.7528.

Twelve JEV strains were isolated, 3 from mosquitoes in 2003 and 10 from pigs in 2004 and 2005. The new JEV sequences were analyzed with a group of 22 previously published JEV strain sequences, including 6 from Thailand and 16 from other Asian countries. A phylogenetic tree was generated, and all 12 JEV new isolates fit into the same GI cluster, as did 3 other Thai strains previously isolated in 1982, 1984, and 1992 (Figure 2). Eleven of the newly identified isolates formed a subcluster (Figure 2, GIa) with 2 other strains previously isolated from Chiang Mai and Khon Ken in 1984 and 1982, respectively (B2239NThailand, P19Br NThailand); the remaining new isolate (JE KK 1116NEThailand2005) was associated with another subcluster (Figure 2, GIb), including strains isolated in 1992 from Chiang Mai (ThCMAr4492) and 3 others isolated from Vietnam, Japan, and Korea (O2VN22; JaNAr0102; and K94P05). Both subclusters were supported by 1,000 bootstrap replications and were consistent with the taxa distance (data not shown) showing introductions of GI in 1982 (within the GIa subcluster followed by a recent dispersion all over the country), and in 1992 for the GIb subcluster followed by local transmission.

GI strains appeared to cluster phylogenetically but not geographically, which suggests virus strains were transported over noncontiguous domains at variable geographic distances. Major environmental changes have occurred since the early 1950s with the increase in local and international transportation systems. Some researchers (10) consider the increase of the virus incidence in the human population to be associated with increased commercial activity. However, because of the low level of viremia in humans, traditionally considered dead-end hosts for JEV, it is more likely that the virus was spread within the country and to neighboring countries by migratory birds, infected domestic pigs, or infected mosquitoes (or their eggs) (11,12).

Although GIII strains were historically reported to circulate mostly in northern Thailand in the early 1980s, GI and GIII were found co-circulating from the north to the south; thereafter, only the GI strain was isolated in Thailand (13). The same genotype shift of GIII to GI, dating back to the early 1990s, was reported by several other Asian countries, including Japan and Korea in 1991 and Vietnam in 2001 (14); a steady emergence and dispersion of GI was also noticed in China in 1979, in Taiwan in the 1980s (13), and in Australia in 2000 (2). Altogether, such unique endemic expansion of GI occurred over a 25-year period in several countries of Southeast Asia, replacing the GIII genotype, which was present all over the region since the beginning of the virus genotype identification (prospectively and retrospectively).

Conclusions

In Thailand, the epidemiologic pattern of Japanese encephalitis first showed a visible decline in incidence with the development of immunization programs, but this decline also corresponded to the late 1980s when the practice of raising pigs in the backyard evolved into industrialized pig farming and the high rate of piglet seroconversion showed an intense virus circulation. The dramatic increase of industrial pig farming and trading must have played a major role in the dispersion of JEV genotypes within past decades in Asia. Concurrently with pig farming, the culicid main vectors have changed (14) and such factors as their ecology, trophic preferences, host competence, and virus fitness could play a role in an evolving rural environment. Moreover, further studies are needed to clarify the expansion of JEV GI strains, including the efficiency of a human and pig GIII-derived vaccine and the role of potential cross-immunity between another circulating flavivirus (13).

Acknowledgments

This study was supported by the Center for Vaccine Development, Mahidol University, Thailand, and the French National Research Agency (ANR / SEST 005), Emergence and Pathogenesis of Infectious Emerging Disease. Research and training of M.N.N. were supported, in part, by the French Research Institute for Development; the Thai Royal Golden Jubilee Fellowship Program; and the Franco-Thai program of the French Embassy in Thailand, sponsored by the French Ministry of Foreign Affairs.

Biography

Dr Nitatpattana is a researcher with the Center for Vaccine Development at Mahidol University. His interest is vaccine development against the major flaviviruses of public health importance in Southeast Asia.

Footnotes

Suggested citation for this article: Nitatpattana N, Dubot-Pérès A, Ar Gouilh M, Souris M, Barbazan P, Yoksan S, et al. Incidence of Japanese encephalitis virus genotype, Thailand. Emerg Infect Dis [serial on the Internet]. 2008 Nov [date cited]. Available from http://www.cdc.gov/EID/content/14/11/1762.htm

References

  • 1.Solomon T, Dung NM, Kneen M, Gainsborough M, Vaughn DW, Khanh VT. Japanese encephalitis. J Neurol Neurosurg Psychiatry. 2000;68:405–15. 10.1136/jnnp.68.4.405 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Pyke AT, Williams DT, Nisbet DJ, van den Hurk AF, Taylor CT, Johansen CA, et al. The appearance of a second genotype of Japanese encephalitis virus in the Australasian region. Am J Trop Med Hyg. 2001;65:747–53. [DOI] [PubMed] [Google Scholar]
  • 3.Tsai TR, Solomon T, Vaughn DW. Flaviviruses (yellow fever, dengue, dengue hemorrhagic fever, Japanese encephalitis, West Nile, St Louis encephalitis, tick-borne encephalitis). In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases, 6th ed. Philadelphia: Elsevier; 2004. p. 1926–50. [Google Scholar]
  • 4.Vaughn DW, Hoke CH Jr. The epidemiology of Japanese encephalitis: prospects for prevention. Epidemiol Rev. 1992;14:197–221. [DOI] [PubMed] [Google Scholar]
  • 5.Solomon T, Ni H, Beasley DW, Ekkelenkamp M, Cardosa MJ, Barrett AD. Origin and evolution of Japanese encephalitis virus in Southeast Asia. J Virol. 2003;77:3091–8. 10.1128/JVI.77.5.3091-3098.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Solomon T. New vaccines for Japanese encephalitis. Lancet Neurol. 2008;7:116–8. 10.1016/S1474-4422(08)70004-8 [DOI] [PubMed] [Google Scholar]
  • 7.Chunsuttiwat S. Japanese encephalitis in Thailand. Southeast Asian J Trop Med Public Health. 1989;20:593–7. [PubMed] [Google Scholar]
  • 8.Moureau G, Temmam S, Gonzalez JP, Charrel RN, Grard G, de Lamballerie X. A real-time RT-PCR method for the universal detection and identification of flaviviruses. Vector Borne Zoonotic Dis. 2007;7:467–77. 10.1089/vbz.2007.0206 [DOI] [PubMed] [Google Scholar]
  • 9.Kumar S, Tamura K, Jakobsen IB, Nei M. MEGA2: Molecular Evolutionary Genetics Analysis software. Bioinformatics. 2001;17:1244–5. 10.1093/bioinformatics/17.12.1244 [DOI] [PubMed] [Google Scholar]
  • 10.Jan LR, Yueh YY, Wu YC, Horng CB, Wang GR. Genetic variation of Japanese encephalitis virus in Taiwan. Am J Trop. 2000;62:446–52. [DOI] [PubMed] [Google Scholar]
  • 11.Mackenzie JS, Gubler DJ, Petersen LR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med. 2004;10(Suppl):S98–109. 10.1038/nm1144 [DOI] [PubMed] [Google Scholar]
  • 12.van den Hurk AF, Johansen CA, Zborowski P, Paru R, Foley PN, Beebe NW, et al. Mosquito host-feeding patterns and implications for Japanese encephalitis virus transmission in northern Australia and Papua New Guinea. Med Vet Entomol. 2003;17:403–11. 10.1111/j.1365-2915.2003.00458.x [DOI] [PubMed] [Google Scholar]
  • 13.Ferguson M, Johnes S, Li L, Heath A, Barrett A. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines—report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies. Biologicals. 2008;36:111–6. 10.1016/j.biologicals.2007.07.002 [DOI] [PubMed] [Google Scholar]
  • 14.Nitatpattana N, Apiwathnasorn C, Barbazan P, Leemingsawat S, Yoksan S, Gonzalez JP. First isolation of Japanese encephalitis from Culex quinquefasciatus in Thailand. Southeast Asian J Trop Med Public Health. 2005;36:875–8. [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES